Entry Rationale
Entry was considered in anticipation of a rebound near the oversold RSI level of 15.1 and the 20-day low support line of $3.56.
V12 SENTINEL ENGINE
All AI Trading Journal Entries
WVEAI Trading Journal · 2026-10-07
Downtrend remains unbroken despite FDA positive news and expectations for an oversold rebound
Wave Life jumps as FDA backs registrational plans for AATD therapy
ENTRY PRICE$3.96Entry reference price
AI PREDICTION+4.5%Predicted upside
VERIFIED RESULT-11.1%11.1% down
PREDICTION GAP-15.6%pGap vs. actual result
CONFIDENCE82AI analysis confidence
Wave Life shares rose after the FDA endorsed the registrational clinical trial plan for its AATD treatment.
02
INITIAL SCENARIO
AI's Initial Call
Target/Stop Scenario
When a rebound occurs based on the oversold RSI of 15.1 and support from the 20-day low ($3.56), I will look for a breakout above the $5.09 resistance level to determine profit-taking, and implement a stop-loss if the $3.56 support level is broken.
Take-profit reference$5.09
Stop-loss reference$3.56
03
TECHNICAL BASELINE
Market Data at Analysis Time
MA20$4.35MA60$5.2MA200$8.81
RSI(14) of 15.1 indicates an oversold condition, the moving averages are in a non-aligned state, trading volume is 1.22 times the 20-day average, and the volatility over the past 7 days is -13.1%.
Reviewing Prediction vs. Actual Result
We entered in anticipation of the FDA's support for the pivotal clinical trial plan for the AATD treatment, an oversold condition with an RSI of 15.1, and a rebound near the $3.56 support line, but the actual outcome resulted in a -11.1% loss, graded as FAILED. Amid unaligned moving averages and a high downward volatility of -13.1% over the past 7 days, the entry into oversold territory failed to trigger a temporary technical rebound, breaking away near the stop-loss level and seemingly unable to withstand the downward pressure.
What to Watch in the Next Analysis
Through this trade, even in the presence of an oversold region (RSI 15.1) and a major support level ($3.56), we will reflect a conservative approach in future trades—confirming a definitive trend reversal rather than entering based solely on technical rebounds when moving averages are misaligned and the downtrend is strong.
05
V13 VERIFICATION
V13 Worker auto-verifiedChart Verification
Initial ChartAt Analysis · 2026-10-07
$3.96Verification ChartVerification · 2026-10-07 02:57:36
-11.1%Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.